Plavix users continue to file lawsuits alleging the popular anti-clotting drug caused serious, internal bleeding. Most recently, the national law firm of Parker Waichman LLP filed 18 Plavix bleeding lawsuits on behalf of people who suffered serious gastrointestinal bleeding, allegedly due to their use of the medication. All of the lawsuits were filed on May 30th in the Supreme Court of New York, County of New York.
Plavix Side Effects
Plavix has been one of the top-selling prescription drugs in the U.S. since it first hit the market in 1997 and has generated billions of dollars in revenue for its makers. As we’ve reported in the past, the makers of Plavix claim it is more effective than regular aspirin in the prevention of heart attack and stroke caused by blood clots. It is often prescribed with a low dose of aspirin to reduce the risk of these complications.
In 2005, the New England Journal of Medicine published a study comparing the effects of Plavix versus Aspirin and esomeprazole in patients who had ulcer bleeding. The study reported an 8.6 percent increased risk of recurrent bleeding in patients taking Plavix versus 0.7 percent among those taking aspirin and esomeprazole.
That same year, the U.S. Food & Drug Administration (FDA) ordered that the Plavix label be updated to include information about reports linking Plavix to thrombotic thrombocytopenic purpura (TTP), condition which is marked by small clots through the entire circulatory system. According to the FDA, some reports of TTP in Plavix patients occurred after only a short exposure (less than two weeks).
In addition to gastrointestinal bleeding and TTP, other potential Plavix side effects include:
- Cerebral hemorrhage
- Internal bleeding
- Bone marrow damage
- Heart attack
Plavix Lawsuit Claims
The 18 Plavix lawsuits filed by Parker Waichman LLP last month all allege that Bristol-Myers Squibb and Sarnoff-Aventis hid the defects of Plavix at the cost of patient safety, and negligently and/or fraudulently represented Plavix to the public as safe and effective for use. All suits allege an increased risk of heart attack, stroke, blood disorders and excessive bleeding. The complaints also allege severe and permanent injuries, physical impairment and disfigurement, physical pain and suffering, mental pain and suffering, loss of enjoyment of life and past, present and future medical expenses as a direct result of the defective drug.